Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / HALO - Halozyme Therapeutics EPS misses by $0.05 beats on revenue


HALO - Halozyme Therapeutics EPS misses by $0.05 beats on revenue

Halozyme Therapeutics (HALO): Q4 GAAP EPS of $0.50 misses by $0.05.Revenue of $121.7M (+126.8% Y/Y) beats by $0.95M.2021 Guidance: Revenues: $375-395M representing 40% to 48% growth Y/Y; EPS of $1.40 to $1.55 representing 54%-70% growth Y/Y and Operating Income of $215-$235M, representing Y/Y growth of 49%-63%.Press Release

For further details see:

Halozyme Therapeutics EPS misses by $0.05, beats on revenue
Stock Information

Company Name: Halozyme Therapeutics Inc.
Stock Symbol: HALO
Market: NASDAQ
Website: halozyme.com

Menu

HALO HALO Quote HALO Short HALO News HALO Articles HALO Message Board
Get HALO Alerts

News, Short Squeeze, Breakout and More Instantly...